(Circulation. 1997;96:3072-3078.)
© 1997 American Heart Association, Inc.
Articles |
Synergistic Effects of ACE Inhibition and Ang II Antagonism on Blood Pressure, Cardiac Weight, and Renin in Spontaneously Hypertensive Rats
From INSERM Unit 367, Paris, France (J.M., M.-F.G.); St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia (D.J.C.); and Broussais Clinical Investigation Center, Assistance Publique des Hôpitaux de Paris and INSERM, Paris, France (M.A.).
Correspondence to Prof Joël Ménard, Hôpital Broussais, 96 rue Didot, 75674 Paris Cedex 14, France.
Background Blockade of type 1 angiotensin (Ang) II receptors combined with ACE inhibition may amplify the efficacy of the renin-angiotensin system blockade because ACE inhibitors do not completely and permanently suppress Ang II production.
Methods and Results Enalapril or losartan (1, 3, 10, and 30 mg/kg) or their combination was administered for 2 to 4 weeks to spontaneously hypertensive rats. The combination of low doses of each agent induced greater reductions in blood pressure (BP) and left ventricular weight/body weight (LVW/BW) ratio than monotherapy with the same or higher doses. When approximately equipotent regimens of enalapril, losartan, and their combination, as judged by BP fall, were compared, there were similar increases in plasma and renal renin and in plasma Ang-(1-7) and Ang I and similar reductions in plasma angiotensinogen. Enalapril alone reduced plasma Ang II levels, and losartan alone increased Ang II levels. The combination of enalapril with losartan prevented or reduced the increase in Ang II levels observed with losartan alone.
Conclusions These findings show that the synergistic interaction between the effects of low doses of enalapril and losartan on BP and LVW/BW ratio is due to more effective inhibition of the renin-angiotensin system by their combination than by either agent alone. When both drugs are given together, the ACE inhibitor–induced fall in plasma Ang II results in modulation of the Ang II antagonist–induced reactive rise in Ang II, thereby lowering the plasma Ang II concentration, which competes with the antagonist for the Ang II receptors.
Key Words: hypertension • blood pressure • angiotensin • enzymes • renin
This article has been cited by other articles:
 |
|
 |
|
  F. H. Messerli The sudden demise of dual renin-angiotensin system blockade or the soft science of the surrogate end point. J. Am. Coll. Cardiol., February 10, 2009; 53(6): 468 - 470. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yamamoto, T. Nakagawa, H. Suzuki, N. Ohashi, H. Fukasawa, Y. Fujigaki, A. Kato, Y. Nakamura, F. Suzuki, and A. Hishida Urinary Angiotensinogen as a Marker of Intrarenal Angiotensin II Activity Associated with Deterioration of Renal Function in Patients with Chronic Kidney Disease J. Am. Soc. Nephrol., May 1, 2007; 18(5): 1558 - 1565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Jacobsen Review: Preventing End-Stage Renal Disease in Diabetic Patients -- Dual Blockade of the Renin-Angiotensin System (Part II) Journal of Renin-Angiotensin-Aldosterone System, June 1, 2005; 6(2): 55 - 68. [Abstract] [PDF]
|
|
|
|
|
|
B. Gurzu, M. Costuleanu, S. M. Slatineanu, A. Ciobanu, and G. Petrescu Are Multiple Angiotensin Receptor Types Involved in Angiotensin (1-7) Actions on Isolated Rat Portal Vein? Journal of Renin-Angiotensin-Aldosterone System, June 1, 2005; 6(2): 90 - 95. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Azizi and J. Menard Combined Blockade of the Renin-Angiotensin System With Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Antagonists Circulation, June 1, 2004; 109(21): 2492 - 2499. [Full Text] [PDF]
|
|
|
|
|
|
P. Trongtorsak, T. O Morgan, and L. M. Delbridge Combined renin-angiotensin system blockade and dietary sodium restriction impairs cardiomyocyte contractility Journal of Renin-Angiotensin-Aldosterone System, December 1, 2003; 4(4): 213 - 219. [Abstract] [PDF]
|
|
|
|
|
|
J. Segura, M. Praga, C. Campo, J. L Rodicio, and L. M Ruilope Combination is better than monotherapy with ACE inhibitor or angiotensin receptor antagonist at recommended doses Journal of Renin-Angiotensin-Aldosterone System, March 1, 2003; 4(1): 43 - 47. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Kim, Y. Izumi, Y. Izumiya, Y. Zhan, M. Taniguchi, and H. Iwao Beneficial Effects of Combined Blockade of ACE and AT1 Receptor on Intimal Hyperplasia in Balloon-Injured Rat Artery Arterioscler Thromb Vasc Biol, August 1, 2002; 22(8): 1299 - 1304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Haddy, D. J. Campbell, W. E. Cayley Jr., J. C. Forfar, S. Munir, J. N. Cohn, and G. Tognoni Valsartan in Chronic Heart Failure N. Engl. J. Med., April 11, 2002; 346(15): 1173 - 1174. [Full Text] [PDF]
|
|
|
|
|
|
T. Morgan, C. Griffiths, and L. Delbridge Interaction of ACE inhibitors and AT1-receptor blockers on maximum blood pressure response in spontaneous hypertensive rats Journal of Renin-Angiotensin-Aldosterone System, March 1, 2002; 3(1): 16 - 18. [Abstract] [PDF]
|
|
|
|
 |
|
 J. L. Wilkinson-Berka, N. J. Gibbs, M. E. Cooper, S. L. Skinner, and D. J. Kelly Renoprotective and anti-hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic (mRen-2)27 rat Nephrol. Dial. Transplant., July 1, 2001; 16(7): 1343 - 1349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. H. Opie and M. N. Sack Enhanced Angiotensin II Activity in Heart Failure : Reevaluation of the Counterregulatory Hypothesis of Receptor Subtypes Circ. Res., April 13, 2001; 88(7): 654 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Abro, C. D Griffiths, T. O Morgan, and L. M. Delbridge Regression of cardiac hypertrophy in the SHR by combined renin-angiotensin system blockade and dietary sodium restriction Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S148 - S153. [Abstract] [PDF]
|
|
|
|
|
|
T. Morgan Review: Effect of combining angiotensin receptor blockers and ACE inhibitors on cardiovascular disease Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S223 - S226. [PDF]
|
|
|
|
|
|
S. Kim, M. Yoshiyama, Y. Izumi, H. Kawano, M. Kimoto, Y. Zhan, and H. Iwao Effects of Combination of ACE Inhibitor and Angiotensin Receptor Blocker on Cardiac Remodeling, Cardiac Function, and Survival in Rat Heart Failure Circulation, January 2, 2001; 103(1): 148 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kawai, S. Y. Stevens, and C.-S. Liang Renin-angiotensin system inhibition on noradrenergic nerve terminal function in pacing-induced heart failure Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H3012 - H3019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Cao, M. E. Cooper, L. L. Wu, A. J. Cox, K. Jandeleit-Dahm, D. J. Kelly, and R. E. Gilbert Blockade of the Renin-Angiotensin and Endothelin Systems on Progressive Renal Injury Hypertension, October 1, 2000; 36(4): 561 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S Weinberg, A. J Weinberg, and D. H Zappe Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors Journal of Renin-Angiotensin-Aldosterone System, September 1, 2000; 1(3): 217 - 233. [PDF]
|
|
|
|
|
|
S. Hanon, P. Vijayaraman, E. H Sonnenblick, and T. H Le Jemtel Persistent formation of angiotensin II despite treatment with maximally recommended doses of angiotensin converting enzyme inhibitors in patients with chronic heart failure Journal of Renin-Angiotensin-Aldosterone System, June 1, 2000; 1(2): 147 - 150. [PDF]
|
|
|
|
 |
|
 S. Kim and H. Iwao Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases Pharmacol. Rev., March 1, 2000; 52(1): 11 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kim, Y. Zhan, Y. Izumi, and H. Iwao Cardiovascular Effects of Combination of Perindopril, Candesartan, and Amlodipine in Hypertensive Rats Hypertension, March 1, 2000; 35(3): 769 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Cerbai, A. Crucitti, L. Sartiani, P. De Paoli, R. Pino, M. L. Rodriguez, G. Gensini, and A. Mugelli Long-term treatment of spontaneously hypertensive rats with losartan and electrophysiological remodeling of cardiac myocytes Cardiovasc Res, January 14, 2000; 45(2): 388 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Ruilope Is it wise to combine an ACE inhibitor and an angiotensin receptor antagonist? Nephrol. Dial. Transplant., December 1, 1999; 14(12): 2855 - 2856. [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Brabant, M. Bertrand, D. Eyraud, P.-L. Darmon, and P. Coriat The Hemodynamic Effects of Anesthetic Induction in Vascular Surgical Patients Chronically Treated with Angiotensin II Receptor Antagonists Anesth. Analg., December 1, 1999; 89(6): 1388 - 1388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tanimura, V. G. Sharov, H. Shimoyama, T. Mishima, T. B. Levine, S. Goldstein, and H. N. Sabbah Effects of AT1-receptor blockade on progression of left ventricular dysfunction in dogs with heart failure Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1385 - H1392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Pitt Regression of Left Ventricular Hypertrophy in Patients With Hypertension : Blockade of the Renin-Angiotensin-Aldosterone System Circulation, November 10, 1998; 98(19): 1987 - 1989. [Full Text] [PDF]
|
|
|
|
|
|
C. Richer, P. Bruneval, J. Menard, and J.-F. Giudicelli Additive Effects of Enalapril and Losartan in (mREN-2)27 Transgenic Rats Hypertension, February 1, 1998; 31(2): 692 - 698. [Abstract] [Full Text] [PDF]
|
|